Recent advances in the development of peptide nucleic acid as a gene-targeted drug

Expert Opinion on Biological Therapy

Volumn 4, Issue 3, 2004, Pages 337-348

  Marin, Violeta L ^a   Roy, Subhadeep ^a   Armitage, Bruce A ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Antigene; Antisense; Gene expression; Hybridisation; Peptide nucleic acid; PNA; Telomerase; Therapeutics

Indexed keywords

ANTIBIOTIC AGENT; COMPLEMENTARY DNA; DOUBLE STRANDED DNA; GENOMIC DNA; GUANINE DERIVATIVE; MESSENGER RNA; PEPTIDE; PEPTIDE NUCLEIC ACID; PLATINUM COMPLEX; RNA;

BACTERICIDAL ACTIVITY; BINDING AFFINITY; DNA BINDING; DNA HYBRIDIZATION; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; REVIEW; RNA BINDING; STRUCTURE ANALYSIS;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); DNA; GENE EXPRESSION; GENE TARGETING; HUMANS; PEPTIDE NUCLEIC ACIDS; RECEPTORS, CELL SURFACE; RNA; TRANSFECTION;

EID: 1542782928     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.4.3.337     Document Type: Review

References (106)

1. NIELSEN PE, EGHOLM M, BERG RH, BUCHARDT O: Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science (1991) 254:1498-1500. This is the original paper on PNA.
2. NIELSEN PE: PNA Technology. In: Peptide nucleic acids. Methods and protocols. Nielsen PE (Ed.), Humana Press, Totowa, NJ, USA (2002):3-26.
3. NIELSEN PE: Peptide nucleic acids: on the road to new gene therapeutic drugs. Pharmacol. Toxicol. (2000) 86:3-7.
4. RAY A, NORDÉN B: Peptide nucleic acid (PNA): Its medical and biotechnical applications and promise for the future. FASEB J. (2000) 14:1041-1060.
5. ELAYADI AN, COREY DR: Application of PNA and LNA oligomers to chemotherapy. Curr. Opin. Investig. Drugs (2001) 2:558-561.
6. EGHOLM M, BUCHARDT O, CHRISTENSEN L et al.: PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature (1993) 365:566-568. This paper describes the hybridisation properties of PNA to single-stranded, mixed sequence targets.
7. TOMAC S, SARKAR M, RATILAINEN T et al.: Ionic effects on the stability and conformation of peptide nucleic acid complexes. J. Am. Chem. Soc. (1996) 118:5544-5552.
8. RATILAINEN T, HOLMÉN A, TUITE E et al.: Hybridization of peptide nucleic acid. Biochemistry (1998) 37:12331-12342.
9. RATILAINEN T, HOLMÉN A, TUITE E, NIELSEN PE, NORDÉN B: Thermodynamics of sequence-specific binding of PNA to DNA. Biochemistry (2000) 39:7781-7791.
10. MAHER LJ III, WOLD B, DERVAN PB: Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science (1989) 245:725-730.
11. MOSER H, DERVAN PB: Sequence-specific cleavage of double helical DNA by triple helix formation. Science (1987) 238:645-650.
12. LE DOAN T, PERROUAULT L, PRASEUTH D et al.: Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[α]-thymidilate covalently linked to an azidoproflavine derivative. Nucleic Acids Res. (1987) 15:7749-7760.
13. BEERLI RR, DREIER B, BARBAS CF: Positive and negative regulation of endogenous genes by designed transcription factors. Proc. Natl. Acad. Sci. USA (2000) 97:1495-1500.
14. DERVAN PB, BURLI RW: Sequence-specific DNA recognition by polyamides. Curr. Opin. Chem. Biol. (1999) 3:688-693.
15. 2/DNA triplex structure upon binding of PNA to dsDNA by strand displacement. J. Mol. Recognit. (1994) 7:165-170.
16. CHERNY DY, BELOTSERKOVSKII BP, FRANK-KAMENETSKII MD et al.: DNA unwinding upon strand-displacement binding of a thymine-substituted polyamide to double-stranded DNA. Proc. Natl. Acad. Sci. USA (1993) 90:1667-1670.
17. PEFFER NJ, HANVEY JC, BISI JE et al.: Strand-invasion of duplex DNA by peptide nucleic acid oligomers. Proc. Natl. Acad. Sci. USA (1993) 90:10648-10652.
18. NIELSEN PE: Peptide nucleic acid: a versatile tool in genetic diagnostics and molecular biology. Curr. Opin. Biotechnol. (2001) 12:16-20.
19. BENTIN T, NIELSEN PE: Enhanced peptide nucleic acid binding to supercoiled DNA: possible implications for DNA 'breathing' dynamics. Biochemistry (1996) 35:8863-8869. This paper illustrates improved strand invasion for supercoiled DNA targets.
20. 2 hybtid quadruplex. J. Am. Chem. Soc. (2003) 125:4111-4118.
21. ARTHANARI H, BOLTON PH: Functional and dysfunctional roles of quadruplex DNA in cells. Chem. Biol. (2001) 8:221-230.
22. CECH TR: Life at the end of the chromosome: telomeres and telomerase. Angew. Chem. Int. Ed. (2000) 39:35-43.
23. SIDDIQUI-JAIN A, GRAND CL, BEARSS DJ, HURLEY LH: Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc. Natl. Acad. Sci. USA (2002) 99:11593-11598.
24. DARNELL JC, JENSEN KB, JIN P, BROWN V, WARREN ST, DARNELL RB: Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell (2001) 107:489-499.
25. DEMIDOV VV, POTAMAN VN, FRANK-KAMANETSKII MD et al.: Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol. (1994) 48:1310-1313. This paper establishes the biochemical stability of PNA.
26. MCMAHON BM, MAYS D, LIPSKY J, STEWART JA, FAUQ A, RICHELSON E: Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. Antisense Nucleic Acid Drug Devel. (2002) 12:65-70. This paper studies the fate of PNA after injection into rats.
27. STEIN CA: Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments. Biochim. Biophys. Acta (1999) 1489:45-52.
28. KOPPELHUS U, NIELSEN PE: Cellular delivery of peptide nucleic acid (PNA). Adv. Drug Deliv. Rev. (2003) 55:267-280.
29. WITTUNG P, KAJANUS J, EDWARDS K, NIELSEN P, NORDÉN B, MALMSTROEM BG: Phospholipid membrane permeability of peptide nucleic acid. FEBS Lett. (1995) 375:27-29.
30. TYLER BM, MCCORMICK DJ, HOSHALL CV et al.: Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo. FEBS Lett. (1998) 421:280-284.
31. TYLER BM, JANSEN K, MCCORMICK DJ et al.: Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc. Natl. Acad. Sci. USA (1999) 96:7053-7058. This paper demonstrates antisense effects of an unmodified PNA that crosses the BBB and enters neuronal cells.
32. FRASER GL, HOLMGREN J, CLARKE PBS, WAHLESTEDT C: Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids. Mol. Pharmacol. (2000) 57:725-731.
33. REZAEI K, XU IS, WU WP et al.: Intrathecal administration of PNA targeting galanin receptor reduces galanin mediated inhibitory effect in the rat spinal cord. Neuroreport (2001) 12:317-320.
34. MCMAHON BM, STEWART JA, BITNER MD, FAUQ A, MCCORMICK DJ, RICHELSON E: Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection. Life Sci. (2002) 71:325-337.
35. MCMAHON BM, STEWART J, FAUQ A, YOUNKIN S, YOUNKIN L, RICHELSON E: Peptide nucleic acids targeted to the amyloid precursor protein. J. Mol. Neurosci. (2003) 20:261-265.
36. ZELPHATI O, SZOKA FC: Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA (1996) 93:11493-11498.
37. HAMILTON SE, SIMMONS CG, KATHIRIYA IS, COREY DR: Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. (1999) 6:343-351. This paper describes transfection of PNA using a carrier DNA.
38. SIMMONS CG, PITTS AE, MAYFIELD LD, SHAY JW, COREY DR: Synthesis and membrane permeability of PNA-peptide conjugates. Bioorg. Med. Chem. Lett. (1997) 7:3001-3006.
39. POOGA M, SOOMETS U, HALLBRINK M et al.: Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. (1998) 16:857-861.
40. CUTRONA G, CARPANETO EM, ULIVI M et al.: Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat. Biotechnol. (2000) 18:300-303. Effective cell uptake, nuclear localisation and antigene activity of a peptide-PNA conjugate are described.
41. CUTRONA G, CARPANETO EM, PONZANELLI A: Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the Eμ enhancer. Cancer Res. (2003) 63:6144-6148.
42. BASU S, WICKSTROM E: Synthesis and characterization of a peptide nucleic acid conjugated to a D-peptide analog of insulin-like growth factor 1 for increased cellular uptake. Bioconj. Chem. (1997) 8:481-488.
43. ALDRIAN-HERRADA G, DESARMÉNIEN MG, ORCEL H et al.: A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res. (1998) 26:4910-4916.
44. GOOD L, AWASTHI SK, DRYSELIUS R, LARSSON O, NIELSEN PE: Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol. (2001) 19:360-364. This paper describes antibiotic properties of PNA directed towards E. coli.
45. KOPPELHUS U, AWASTHI SK, ZACHAR V, HOLST HU, EBBESEN P, NIELSEN PE: Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Devel. (2002) 12:51-63.
46. VOCERO-AKBANI AM, HEYDEN NV, LISSY NA, RATNER L, DOWDY SF: Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat. Med. (1999) 5:29-33.
47. LEWIN M, CARLESSO N, TUNG C et al.: Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. (2000) 18:410-414.
48. WENDER PA, MITCHELL DJ, PATTABIRAMAN K, PELKEY ET, STEINMAN L, ROTHBARD JB: The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA (2000) 97:13003-13008.
49. ZHOU P, WANG M, DU L, FISHER GW, WAGGONER A, LY DH: Novel binding and efficient cellular uptake of guanidine-based peptide nucleic acids (GPNA). J. Am. Chem. Soc. (2003) 125:6878-6879. This paper describes cell uptake and DNA binding properties of a cationic PNA analogue.
50. HAAIMA G, LOHSE A, BUCHARDT O, NIELSEN PE: Peptide nucleic acids (PNAs) containing thymine monomers derived from chiral amino acids: hybridization and solubility properties of D-lysine PNA. Angew. Chem. Int. Ed. (1996) 35:1939-1942. This paper reports on backbone-modified PNAs.
51. PÜSCHL A, SFORZA S, HAAIMA G, DAHL O, NIELSEN PE: Peptide nucleic acids (PNAs) with a functional backbone. Tetrahedron Lett. (1998) 39:4707-4710.
52. SFORZA S, CORRADINI R, GHIRARDI S, DOSSENA A, MARCHELLI R: DNA binding of a D-lysine-based chiral PNA: direction control and mismatch recognition. Eur. J. Org. Chem. (2000):2905-2913.
53. PARDRIDGE WM, BOADA RJ, KANG Y: Vector-mediated delivery of a polyamide ('peptide') nucleic acid analogue through the blood-brain barrier in vivo. Proc. Natl. Acad. Sci. USA (1995) 92:5592-5596. This was also the first paper that demonstrated PNA antisense in live animals.
54. ZHANG X, SIMMONS C, COREY DR: Liver cell specific targeting of peptide nucleic acid oligomers. Bioorg. Med. Chem. Lett. (2001) 11:1269-1272.
55. HAMZAVI R, DOLLE F, TAVITIAN B, DAHL O, NIELSEN PE: Modulation of the pharmacokinetic properties of PNA: preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. Bioconj. Chem. (2003) 14:941-954. This paper reports backbone-modified PNAs with improved tissue targeting.
56. LANGER K, COESTER C, WEBER C, VON BRIESEN H, KREUTER J: Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid. Eur. J. Pharmaceut. Biopharmaceut. (2000) 49:303-307.
57. COESTER C, KREUTER J, VON BRIESEN H, LANGER K: Preparation of avidin-labeled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA). Int. J. Pharm. (2000) 196:147-149.
58. MURATOVSKA A, LIGHTOWLERS RN, TAYLOR RW et al.: Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res. (2001) 29:1852-1863.
59. LJUNGSTROM T, KNUDSEN H, NIELSEN PE: Cellular uptake of adamantyl conjugated peptide nucleic acids. Bioconj. Chem. (1999) 10:965-972.
60. SCARFI S, GASPARINI A, DAMONTE G, BENATTI U: Synthesis, uptake, and intracellular metabolism of a hydrophobic tetrapeptide-peptide nucleic acid (PNA)-biotin molecule. Biochem. Biophys. Res. Commun. (1997) 236:323-326.
61. BOFFA LC, SCARFI S, MARIANI MR et al.: Dihydrotestosterone as a selective cellular/nuclear localization vector for antigene peptide nucleic acid in prostatic carcinoma cells. Cancer Res. (2000) 60:2258-2262. Antigene PNAs are targeted to prostate cancer cells using a conjugated steroid group.
62. REBUFFAT AG, NAWROCKI AR, NIELSEN PE et al.: Gene delivery by a steroid-peptide nucleic acid conjugate. FASEB J. (2002) 16:1426-1428.
63. KARRAS JG, MAIER MA, LU T, WATT A, MANOHARAN M: Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-α chain. Biochemistry (2001) 40:7853-7859. This paper demonstrates the use of PNA to regulate RNA splicing as a way of controlling gene expression.
64. CHEAH IK, CHEEMA SS, LANGFORD SJ et al.: Design and application of a peptide nucleic acid sequence targeting the p75 neurotrophin receptor. Bioorg. Med. Chem. Lett. (2003) 13:2377-2380.
65. ADLERZ L, SOOMETS U, HOLMLUND L, VIIRLAID S, LANGEL U, IVERFELDT K: Down-regulation of amyloid precursor protein by peptide nucleic acid oligomer in cultured rat primary neurons and astrocytes. Neurosci Lett. (2003) 336:55-59.
66. MCMAHON BM, STEWART J, FAUQ A, YOUNKIN S, YOUNKIN L, RICHELSON E: Using peptide nucleic acids as gene-expression modifiers to reduce beta-amyloid levels. J. Mol. Neurosci. (2002) 19:71-76.
67. LUGER K, MADER AW, RICHMOND RK, SARGENT DF, RICHMOND TJ: Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature (1997) 389:251-260.
68. GOTTESFELD JM, MELANDER C, SUTO RK, RAVIOL H, LUGER K, DERVAN PB: Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides. J. Mol. Biol. (2001) 309:615-629.
69. BOFFA LC, CARPANETO EM, ALLFREY VG: Isolation of active genes containing CAG repeats by DNA strand invasion by a peptide nucleic acid. Proc. Natl. Acad. Sci. USA (1995) 92:1901-1905.
70. BOFFA LC, MORRIS PL, CARPANETO EM, LOUISSAINT M, ALLFREY VG: Invasion of the CAG triplet repeats by a complementary peptide nucleic acid inhibits transcription of the androgen receptor and TATA-binding protein genes and correlates with refolding of an active nucleosome containing a unique AR gene sequence. J. Biol. Chem. (1996) 271:13228-13233.
71. CROOKE ST: Comments on evaluation of antisense drugs in the clinic. Antisense Nucleic Acid Drug Dev. (2000) 10:225-227.
72. GOOD L, NIELSEN PE: Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc. Natl. Acad. Sci. USA (1998) 95:2073-2076.
73. GOOD L, NIELSEN PE: Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat. Biotechnol. (1998) 16:355-358.
74. STOCK RP, OLVERA A, SÁNCHEZ R et al.: Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers. Nat. Biotechnol. (2001) 19:231-234.
75. MØLLEGAARD NE, BUCHARDT O, EGHOLM M, NIELSEN PE: Peptide nucleic acid. DNA strand displacement loops as artificial transcription promoters. Proc. Natl. Acad. Sci. USA (1994) 91:3892-3895. This paper demonstrates that a PNA strand invasion complex can act as an artificial promoter for transcription.
76. WANG G, XU X, PACE B et al.: Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression. Nucleic Acids Res. (1999) 27:2806-2813. This paper demonstrates that PNA strand invasion can activate gene expression in cells.
77. MAPP AK, ANSARI AZ, PTASHNE M, DERVAN PB: Activation of gene expression by small molecule transcription factors. Proc. Natl. Acad. Sci. USA (2000) 97:3930-3935.
78. STANOJEVIC D, YOUNG RA: A highly potent artificial transcription factor. Biochemistry (2002) 41:7209-7216.
79. LIU B, HAN Y, FERDOUS A, COREY DR, KODADEK T: Transcription activation by a PNA-peptide chimera in a mammalian cell extract. Chem. Biol. (2003) 10:909-916.
80. NORTON JC, PIATYSZEK MA, WRIGHT WE, SHAY JW, COREY DR: Inhibition of human telomerase activity by peptide nucleic acids. Nat. Biotechnol. (1996) 14:615-619. This paper demonstrates PNA targeting of an RNA-protein complex and inhibition of enzymatic function.
81. HAMILTON SE, PITTS AE, KATIPALLY RR et al.: Identification of determinants for inhibitor binding within the active site of human telomerase using PNA scanning. Biochemistry (1997) 36:11873-11880.
82. PITTS AE, COREY DR: Inhibition of human telomerase by 2′-O-methyl RNA. Proc. Natl. Acad. Sci. USA (1998) 95:11549-11554.
83. HARRISON JG, FRIER C, LAURANT R, DENNIS R, RANEY KD, BALASUBRAMANIAN S: Inhibition of human telomerase by PNA-cationic peptide conjugates. Bioorg. Med. Chem. Let. (1999) 9:1273-1278.
84. VILLA R, FOLINI M, LUALDI S, VERONESE S, DAIDONE MG, ZAFFARONI N: Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells. FEBS Lett. (2000) 473:241-248.
85. HERBERT BS, PITTS AE, BAKER SI et al.: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. USA (1999) 96:14276-14281.
86. AUTEXIER C: Telomerase as a possible target for anticancer therapy. Chem. Biol. (1999) 6:R299-R303.
87. KARRAS JG, MCKAY RA, DEAN NM, MONIA BP: Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing. Mol. Pharmacol. (2000) 58:380-387.
88. SAZANI P, GEMIGNANI F, KANG S-H et al.: Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. (2002) 20:1228-1233. This paper describes the effect of a splice site-selecting PNA in whole animals.
89. BORGATTI M, ROMANELLI A, SAVIANO M et al.: Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum. Oncol. Res. (2003) 13:279-287.
90. BORGATTI M, LAMPRONTI I, ROMANELLI A et al.: Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol. Chem. (2003) 278:7500-7509.
91. BORGATTI M, BREDA L, CORTESI R et al.: Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors. Biochem. Pharmacol. (2002) 64:609-616.
92. MISCHIATI C, BORGATTI M, FERIOTTO G et al.: Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking: the NF-kappaB binding site. Int. J. Mol. Med. (2002) 9:633-639.
93. HECKL S, PIPKORN R, WALDECK W: Intracellular visualization of prostate cancer using magnetic resonance imaging. Cancer Res. (2003) 63:4766-4772.
94. LEE HJ, BOADO RJ, BRAASCH DA, COREY DR, PARDRIDGE WM: Imaging gene expression in brain in vivo in transgenic mouse model of Huntington's disease with antisense radiopharmaceutical and drug-targeting technology. J. Nucl. Med. (2002) 43:948-956.
95. SHI N, BOADO RJ, PARDRIDGE WM: Antisense imaging of gene expression in the brain in vivo. Prac. Natl. Acad. Sci. USA (2000) 97:14709-14714.
96. TACKETT AJ, COREY DR, RANEY KD: Non-Watson-Crick interactions between PNA and DNA inhibit the ATPase activity of bacteriophage T4 Dda helicase. Nucleic Acids Res. (2002) 30:950-957.
97. DOYLE DF, BRAASCH DA, SIMMONS CG, JANOWSKI BA, COREY DR: Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry (2001) 40:53-64. This paper provides a comprehensive study of PNA antisense in cells and shows how inhibition of translation is highly context dependent.
98. KNUDSEN H, NIELSEN PE: Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res. (1996) 24:494-500. This paper demonstrates that homopyrimidine PNAs can be effective antisense agents, indicating that triplex formation can improve therapeutic potential.
99. HAYES JJ, TULLIUS T, WOLFFE AP: The structure of DNA in a nucleosome. Proc. Natl. Acad. Sci. USA (1990) 87:1229-1233.
100. GOTTESFELD JM, MELANDER C, SUTO RK, RAVIOL H, LUGER K, DERVAN PB: Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides. J. Mol. Biol. (2001) 309:615-629.
101. LOHSE J, DAHL O, NIELSEN PE: Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proc. Natl. Acad. Sci. USA (1999) 96:11804-11808. The double-duplex invasion strategy significantly extends PNA recognition of double-stranded DNA.
102. DEMIDOV W, PROTOZANOVA E, IZVOLSKY KI, PRICE C, NIELSEN PE, FRANK-KAMANETSKII MD: Kinetics and mechanism of the DNA double helix invasion by pseudocomplementary peptide nucleic acids. Proc. Natl. Acad. Sci. USA (2002) 99:5953-5958.
103. SCHMIDT KS, BOUDVILLAIN M, SCHWARTZ A et al.: Monofunctionally trans-diammine platinum (II)-modified peptide nucleic acid oligomers: a new generation of potential antisense drugs. Chem. Eur. J. (2002) 8:5566-5570.
104. LAGOS-QUINTANA M, RAUHUT R, LENDECKEL W, TUSCHL T: Identification of novel genes coding for small expressed RNAs. Science (2001) 294:853-858.
105. LAU NC, LIM LP, WEINSTEIN EG, BARTEL DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science (2001) 294:858-862.
106. LEE RC, AMBROS V: An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 294:862-864.